BLFS
Price
$24.34
Change
-$0.98 (-3.87%)
Updated
Aug 15 closing price
Capitalization
1.17B
82 days until earnings call
STXS
Price
$2.73
Change
-$0.17 (-5.86%)
Updated
Aug 15 closing price
Capitalization
246.38M
82 days until earnings call
Interact to see
Advertisement

BLFS vs STXS

Header iconBLFS vs STXS Comparison
Open Charts BLFS vs STXSBanner chart's image
BioLife Solutions
Price$24.34
Change-$0.98 (-3.87%)
Volume$1.3M
Capitalization1.17B
Stereotaxis
Price$2.73
Change-$0.17 (-5.86%)
Volume$464.8K
Capitalization246.38M
BLFS vs STXS Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. STXS commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (BLFS: $24.34 vs. STXS: $2.73)
Brand notoriety: BLFS and STXS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BLFS: 244% vs. STXS: 88%
Market capitalization -- BLFS: $1.17B vs. STXS: $246.38M
BLFS [@Pharmaceuticals: Other] is valued at $1.17B. STXS’s [@Pharmaceuticals: Other] market capitalization is $246.38M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $172.16B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, BLFS is a better buy in the long-term than STXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 5 TA indicator(s) are bullish while STXS’s TA Score has 5 bullish TA indicator(s).

  • BLFS’s TA Score: 5 bullish, 5 bearish.
  • STXS’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Pharmaceuticals: Other) experienced а +7.32% price change this week, while STXS (@Pharmaceuticals: Other) price change was +9.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.53%. For the same industry, the average monthly price growth was -0.29%, and the average quarterly price growth was +4.24%.

Reported Earning Dates

BLFS is expected to report earnings on Nov 06, 2025.

STXS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.53% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($1.17B) has a higher market cap than STXS($246M). STXS YTD gains are higher at: 19.737 vs. BLFS (-6.240). BLFS has higher annual earnings (EBITDA): 2.72M vs. STXS (-24.72M). BLFS has more cash in the bank: 88.6M vs. STXS (10.6M). STXS has less debt than BLFS: STXS (5.87M) vs BLFS (26.9M). BLFS has higher revenues than STXS: BLFS (87.8M) vs STXS (27.5M).
BLFSSTXSBLFS / STXS
Capitalization1.17B246M474%
EBITDA2.72M-24.72M-11%
Gain YTD-6.24019.737-32%
P/E RatioN/AN/A-
Revenue87.8M27.5M319%
Total Cash88.6M10.6M836%
Total Debt26.9M5.87M458%
FUNDAMENTALS RATINGS
BLFS vs STXS: Fundamental Ratings
BLFS
STXS
OUTLOOK RATING
1..100
5384
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
4738
P/E GROWTH RATING
1..100
1361
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BLFS's Valuation (99) in the Medical Specialties industry is in the same range as STXS (100). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

BLFS's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as STXS (100). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

BLFS's SMR Rating (91) in the Medical Specialties industry is in the same range as STXS (100). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as BLFS (47). This means that STXS’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (13) in the Medical Specialties industry is somewhat better than the same rating for STXS (61). This means that BLFS’s stock grew somewhat faster than STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSSTXS
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 16 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FJTSY23.730.03
+0.13%
Fujitsu Ltd.
CYAGF8.08N/A
N/A
Cyber Agent Inc.
BTSDF1.26N/A
N/A
Health & Happiness International Holdings Ltd.
ACHFF1.21-0.02
-1.63%
Arch Biopartners Inc.
ZUUZF0.11N/A
-2.32%
Zeus North America Mining Corp.

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
-3.87%
RGEN - BLFS
56%
Loosely correlated
-1.81%
RVTY - BLFS
51%
Loosely correlated
+1.49%
A - BLFS
50%
Loosely correlated
+0.28%
DHR - BLFS
47%
Loosely correlated
+0.34%
ITGR - BLFS
46%
Loosely correlated
+0.02%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
-5.86%
SMTI - STXS
37%
Loosely correlated
-2.37%
TWST - STXS
36%
Loosely correlated
-2.50%
CERS - STXS
35%
Loosely correlated
-2.36%
RGEN - STXS
33%
Loosely correlated
-1.81%
BLFS - STXS
33%
Poorly correlated
-3.87%
More